Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity
出版年份 2018 全文链接
标题
Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity
作者
关键词
Breast cancer, Endocrine treatment, Adherence, Tamoxifen, Comorbidity
出版物
BREAST CANCER RESEARCH AND TREATMENT
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2018-07-21
DOI
10.1007/s10549-018-4890-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Good adherence to adjuvant endocrine therapy in early breast cancer – a population-based study based on the Swedish Prescribed Drug Register
- (2018) Christine Lundgren et al. ACTA ONCOLOGICA
- Association Between Out-Of-Pocket Costs, Race/Ethnicity, and Adjuvant Endocrine Therapy Adherence Among Medicare Patients With Breast Cancer
- (2017) Albert J. Farias et al. JOURNAL OF CLINICAL ONCOLOGY
- Polypharmacy and Adherence to Adjuvant Endocrine Therapy for Breast Cancer
- (2017) Gregory S. Calip et al. Journal of Oncology Practice
- Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: the Breast Cancer Quality of Care Study (BQUAL)
- (2016) Dawn L. Hershman et al. BREAST CANCER RESEARCH AND TREATMENT
- Behavioral Interventions to Enhance Adherence to Hormone Therapy in Breast Cancer Survivors: A Systematic Literature Review
- (2016) Alejandra Hurtado-de-Mendoza et al. Clinical Breast Cancer
- Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence
- (2016) Jacquie H. Chirgwin et al. JOURNAL OF CLINICAL ONCOLOGY
- Mapping the Decision-Making Process for Adjuvant Endocrine Therapy for Breast Cancer
- (2016) Louise L. Beryl et al. MEDICAL DECISION MAKING
- Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years
- (2016) Paul E. Goss et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nonadherence to Medications for Chronic Conditions and Nonadherence to Adjuvant Hormonal Therapy in Women With Breast Cancer
- (2016) Alfred I. Neugut et al. JAMA Oncology
- Household Net Worth, Racial Disparities, and Hormonal Therapy Adherence Among Women With Early-Stage Breast Cancer
- (2015) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictors of Discontinuation of Adjuvant Hormone Therapy in Patients With Breast Cancer
- (2015) Wei He et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of Fertility Concerns on Tamoxifen Initiation and Persistence
- (2015) Natalia C. Llarena et al. JNCI-Journal of the National Cancer Institute
- Medication Adherence Measures: An Overview
- (2015) Wai Yin Lam et al. Biomed Research International
- Impact of Fertility Concerns on Tamoxifen Initiation and Persistence
- (2015) Natalia C. Llarena et al. JNCI-Journal of the National Cancer Institute
- The value of high adherence to tamoxifen in women with breast cancer: a community-based cohort study
- (2013) C McCowan et al. BRITISH JOURNAL OF CANCER
- Information needs of post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapy
- (2013) Deb Feldman-Stewart et al. PATIENT EDUCATION AND COUNSELING
- Adherence and discontinuation of oral hormonal therapy in patients with hormone receptor positive breast cancer
- (2013) Lorena Rocha Ayres et al. International Journal of Clinical Pharmacy
- Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study
- (2012) Annette Wigertz et al. BREAST CANCER RESEARCH AND TREATMENT
- Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review
- (2012) Caitlin C. Murphy et al. BREAST CANCER RESEARCH AND TREATMENT
- Early discontinuation of tamoxifen intake in younger women with breast cancer: Is it time to rethink the way it is prescribed?
- (2012) Laetitia Huiart et al. EUROPEAN JOURNAL OF CANCER
- Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
- (2012) Christina Davies et al. LANCET
- Predicting Adherence to Tamoxifen for Breast Cancer Adjuvant Therapy and Prevention
- (2011) J. H. Lin et al. Cancer Prevention Research
- Medication Adherence: WHO Cares?
- (2011) Marie T. Brown et al. MAYO CLINIC PROCEEDINGS
- Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer
- (2010) Rebecca L. Sedjo et al. BREAST CANCER RESEARCH AND TREATMENT
- American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer
- (2010) Harold J. Burstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis
- (2008) Ivana Sestak et al. LANCET ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started